A detailed history of Macroview Investment Management LLC transactions in Exact Sciences Corp stock. As of the latest transaction made, Macroview Investment Management LLC holds 36 shares of EXAS stock, worth $2,017. This represents 0.0% of its overall portfolio holdings.

Number of Shares
36
Previous 36 -0.0%
Holding current value
$2,017
Previous $1,000 100.0%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 30, 2024

SELL
$56.27 - $73.77 $5,739 - $7,524
-102 Reduced 73.91%
36 $2,000
Q4 2023

Jan 30, 2024

SELL
$59.06 - $75.72 $708 - $908
-12 Reduced 8.0%
138 $10,000
Q3 2023

Oct 26, 2023

BUY
$65.94 - $99.04 $1,714 - $2,575
26 Added 20.97%
150 $10,000
Q2 2023

Jul 13, 2023

SELL
$62.68 - $95.05 $2,319 - $3,516
-37 Reduced 22.98%
124 $11,000
Q1 2023

Apr 18, 2023

BUY
$47.19 - $70.77 $7,597 - $11,393
161 New
161 $10,000

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $9.92B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Macroview Investment Management LLC Portfolio

Follow Macroview Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Macroview Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Macroview Investment Management LLC with notifications on news.